Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYP2D6 Genotype and Codeine Response in Sickle Cell Disease
NCT00174538Phase 2Completed
- Sponsor
- PriCara
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of codeine in sickle cell disease (SCD), sponsored by PriCara. Primary endpoints: Plasma morphine and codeine concentrations and CYP2D6 genotype. Started Mar 2005; status: completed.
02
Drugs
codeine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT00174538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174538.